Status:

COMPLETED

Open-Label, Safety and Tolerability Extension Study of KNS-760704 in Amyotrophic Lateral Sclerosis (ALS) (CL211)

Lead Sponsor:

Knopp Biosciences

Conditions:

Amyotrophic Lateral Sclerosis

Eligibility:

All Genders

21-80 years

Phase:

PHASE2

Brief Summary

This is an open-label, multi-center study designed to extend the evaluation of the safety, tolerability, and clinical effects of oral administration of KNS-760704 in patients with ALS.

Detailed Description

Patients who complete the Part 2 Week 28 visit in study KNS-760704-CL201 and patients with ALS who were actively receiving RTPB \[(6R)-4,5,6,7-tetrahydro-N6-propyl-2,6-benzothiazolediamine dihydro-chl...

Eligibility Criteria

Inclusion

  • Patient has provided signed informed consent for this trial before the commencement of any study-related procedure
  • Patient is actively participating in Knopp Protocol KNS-760704-CL201 and has completed the Part 2 Week 28 visit in that study or patient is actively receiving RTPB under Research IND #60,948

Exclusion

  • Patient did not participate in Knopp Protocol KNS-760704-CL201 or patient did not receive RTPB under Research IND #60,948.
  • Patient discontinued from KNS-760704-CL201 for any reason other than enrollment into this study (applies to patients enrolled in KNS-760704-CL201 only)
  • Patient was not taking RTPB under Research IND #60,948 prior to April 30, 2009 (applies to patients enrolled under Research IND #60,948 only)

Key Trial Info

Start Date :

July 1 2009

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

July 1 2013

Estimated Enrollment :

74 Patients enrolled

Trial Details

Trial ID

NCT00931944

Start Date

July 1 2009

End Date

July 1 2013

Last Update

August 16 2021

Active Locations (19)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 5 (19 locations)

1

University of Arkansas for Medical Sciences

Little Rock, Arkansas, United States, 72205

2

UCLA, Dept. of Neurology - Neuromuscular/ALS Research Center

Los Angeles, California, United States, 90095

3

The Forbes Norris MDA/ALS Research Center

San Francisco, California, United States, 94115

4

University of Miami Miller School of Medicine

Miami, Florida, United States, 33136